Palmitoylation-based targeting methods may provide more powerful and long-lasting inhibitory effects because they inhibit PD-L1 protein levels throughout the cell and therefore may represent a promising therapeutic avenue toward enhancing tumor-specific immunity. Here, CD274 is linked to neoplasm.